Cipla has now entered into obesity Market with a partnership with Eli Lilly for Tirzepatide (GLP-1) is exclusive to the ...
Macquarie maintains an outperform rating on Hindustan Unilever, anticipating sales growth above 4% driven by demand recovery ...
Novartis to acquire Avidity for USD 72.00 per share in cash for total equity value of approximately USD 12.0 billion Avidity ...
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...
A particularly noteworthy achievement emerged this quarter: Eli Lilly's tirzepatide franchise overtook Merck's cancer immunotherapy Keytruda to become the world's highest-grossing medication. This ...
The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...
GlobalData on MSN
GSK forges pact with Empirico for respiratory siRNA in $745m deal
GSK now has the global development and commercialisation rights to the COPD-targeting oligonucleotide, EMP-012.
Wall Street followed the FTSE 100 lower on Thursday as traders digested the next tranche of Big Tech earnings, after a mixed ...
Yahoo Finance is chronicling the latest news and updates on President Trump's plans to impose tariffs on goods from other ...
Yahoo Finance is chronicling the latest news and updates on President Trump's plans to impose tariffs on goods from other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback